|
CASK expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.893600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.365000E-01 |
| Normal-vs-Stage2 |
6.038000E-01 |
| Normal-vs-Stage3 |
9.911900E-02 |
| Normal-vs-Stage4 |
3.716200E-01 |
| Stage1-vs-Stage2 |
3.166800E-01 |
| Stage1-vs-Stage3 |
3.911900E-02 |
| Stage1-vs-Stage4 |
1.602180E-01 |
| Stage2-vs-Stage3 |
5.059000E-01 |
| Stage2-vs-Stage4 |
8.900800E-01 |
| Stage3-vs-Stage4 |
4.903400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.484600E-01 |
| Normal-vs-AfricanAmerican |
5.011700E-02 |
| Normal-vs-Asian |
1.361230E-01 |
| Caucasian-vs-AfricanAmerican |
1.021380E-01 |
| Caucasian-vs-Asian |
2.250100E-02 |
| AfricanAmerican-vs-Asian |
6.961500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.479800E-02 |
| Normal-vs-Female |
2.075000E-01 |
| Male-vs-Female |
8.377400E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.827400E-01 |
| Normal-vs-Age(41-60Yrs) |
2.798400E-01 |
| Normal-vs-Age(61-80Yrs) |
8.460000E-01 |
| Normal-vs-Age(81-100Yrs) |
2.916800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.150200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.516800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.321000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.433200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.524800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.864200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.821000E-01 |
| Normal-vs-Grade 2 |
2.068000E-01 |
| Normal-vs-Grade 3 |
4.622200E-02 |
| Normal-vs-Grade 4 |
1.005980E-01 |
| Grade 1-vs-Grade 2 |
7.952600E-01 |
| Grade 1-vs-Grade 3 |
2.216600E-01 |
| Grade 1-vs-Grade 4 |
1.796220E-01 |
| Grade 2-vs-Grade 3 |
5.084300E-03 |
| Grade 2-vs-Grade 4 |
2.725600E-02 |
| Grade 3-vs-Grade 4 |
8.362000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.117200E-01 |
| Normal-vs-ccB subtype |
5.510400E-01 |
| ccA subtype-vs-ccB subtype |
3.625800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.813600E-01 |
| Normal-vs-N1 |
7.966600E-01 |
| N0-vs-N1 |
6.805800E-01 |
|
|
